Global Intravenous Sets Market Size By Type (Primary IV Sets, Secondary IV Sets), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Intravenous Sets Market was valued at USD 10.4 billion in 2023 and is projected to reach USD 16.7 billion by 2031, growing at a CAGR of 6.2% during the forecast period from 2023 to 2031. The market is primarily driven by the increasing prevalence of chronic diseases, rising number of surgical procedures, and the growing demand for efficient and safe drug delivery systems. Intravenous (IV) sets are essential components in healthcare settings, facilitating the controlled administration of fluids, medications, and nutrients directly into the bloodstream.

Drivers:

Rising Incidence of Chronic Diseases:

The increasing global burden of chronic illnesses, such as diabetes, cancer, and cardiovascular conditions, necessitates long-term medication management, often delivered intravenously. This significantly fuels the demand for IV sets in hospitals and homecare settings.

Growth in Surgical Procedures:

An upsurge in surgical interventions globally, due to improved access to healthcare and an aging population, has led to a corresponding rise in the use of IV sets for anesthesia, hydration, and medication delivery.

Technological Advancements:

The introduction of needle-free connectors, flow regulators, and safety-engineered IV sets is enhancing patient safety and reducing the risk of infections and needlestick injuries, thereby encouraging broader adoption.

Restraints:

High Risk of Infections:

Despite technological improvements, IV therapy is still associated with risks of bloodstream infections if not managed properly, which may limit market penetration in some under-resourced settings.

Stringent Regulatory Approvals:

The IV set market is subject to rigorous regulatory scrutiny, which can delay the time-to-market for new products and add to development costs, affecting smaller manufacturers in particular.

Opportunity:

Home Healthcare and Geriatric Population Growth:

The expanding home healthcare market, particularly for elderly and chronically ill patients, is a major opportunity for IV set manufacturers. The convenience of home-based infusion therapy is contributing to increased demand.

Adoption in Emerging Economies:

Countries in Asia-Pacific and Latin America are witnessing growing investments in healthcare infrastructure and services, creating substantial opportunities for IV set providers to enter and expand in these markets.

Market by System Type Insights:

By system type, primary IV sets dominated the market in 2023, owing to their extensive use in continuous medication infusion. However, secondary IV sets are projected to experience the fastest growth during the forecast period due to their increasing application in intermittent drug administration and compatibility with infusion pumps and automated systems.

Market by End-use Insights:

The hospital segment held the largest revenue share in 2023, supported by high patient volumes, advanced treatment capabilities, and extensive use of IV therapy in inpatient care. Meanwhile, the homecare segment is expected to grow rapidly, driven by patient preferences for cost-effective and convenient healthcare delivery at home, especially for long-term treatments.

Market by Regional Insights:

North America led the market in 2023, backed by strong healthcare infrastructure, high adoption of advanced medical devices, and the presence of key manufacturers. Asia-Pacific is forecasted to grow at the highest rate during 2023–2031 due to an increasing patient pool, rising healthcare awareness, and expanding hospital networks across China, India, and Southeast Asia.

Competitive Scenario:

Key players in the global intravenous sets market include B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Inc., Fresenius Kabi AG, Nipro Corporation, Terumo Corporation, Smiths Medical, CODAN Medizinische Geräte GmbH & Co KG, Poly Medicure Ltd., and Vygon SA. These companies are focusing on product innovation, safety enhancements, strategic collaborations, and geographic expansion to maintain competitive advantages.

Scope of Work – Global Intravenous Sets Market

Report Metric Details

Market Size (2023) USD 10.4 billion

Projected Market Size (2031) USD 16.7 billion

CAGR (2023–2031) 6.2%

Market Segments By System Type, End-use, Region

Growth Drivers Rise in chronic diseases, surgical procedures, and safety-focused technologies

Opportunities Home healthcare growth, emerging market expansion

Key Market Developments:

2023: Baxter International Inc. launched a new IV set featuring integrated anti-siphon valves and closed system connectors to enhance patient safety and comply with global regulatory standards.

2024: ICU Medical announced a partnership with a major health system in Europe to provide custom IV set solutions integrated with smart infusion pumps.

2025: B. Braun expanded its IV therapy manufacturing facility in Asia to meet increasing regional demand and improve supply chain efficiency.

FAQs:

What is the current market size of the Global Intravenous Sets Market?

The market size was USD 10.4 billion in 2023.

What is the major growth driver of the Global Intravenous Sets Market?

The increasing prevalence of chronic diseases and growing number of surgical procedures.

Which is the largest region during the forecast period in the Global Intravenous Sets Market?

North America held the largest market share in 2023.

Which segment accounted for the largest market share in the Global Intravenous Sets Market?

The hospital segment dominated the market by end-use in 2023.

Who are the key market players in the Global Intravenous Sets Market?

Major players include B. Braun Melsungen AG, Baxter International Inc., ICU Medical, Fresenius Kabi, and Terumo Corporation.

Would you like a chart visualizing the market size and CAGR trends?